Placental protein 5 (PP5) in pregnancy and malignant disease: the influence of heparin binding
- 1 February 1982
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 119 (1-2) , 21-29
- https://doi.org/10.1016/0009-8981(82)90401-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- PLACENTAL PROTEIN 5 (PP5): DEVELOPMENT OF A RADIOIMMUNOASSAY AND MEASUREMENT OF CIRCULATING LEVELS IN NORMAL PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- Specific interaction between placentae protein 5 and heparinClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- DETECTION OF PLACENTAL PROTEIN-5 (PP5) AND PREGNANCY-SPECIFIC GLYCOPROTEIN (SP1) IN BENIGN AND MALIGNANT BREAST DISEASE1981
- Molecular heterogeneity of placental protein 5 (pp5) in late pregnancy serum and plasma: evidence for a heparin-pp5 polymerClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- The radioimmunoassay of placental protein 5 and circulating levels in maternal blood in the third trimester of normal pregnancyClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and tropho‐blastic disease: Absence of PP5 expression in the malignant trophoblastInternational Journal of Cancer, 1979
- Isolierung und Charakterisierung des Plazenta-Proteins PP5Archiv für Gynäkologie, 1977
- The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassayBiochemical Journal, 1973
- Nachweis und Charakterisierung von löslichen Antigenen in der menschlichen PlacentaArchiv für Gynäkologie, 1972